 |
PDBsum entry 1r88
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
1r88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
335:519-530
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
The structure of Mycobacterium tuberculosis MPT51 (FbpC1) defines a new family of non-catalytic alpha/beta hydrolases.
|
|
R.A.Wilson,
W.N.Maughan,
L.Kremer,
G.S.Besra,
K.Fütterer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Mycobacterium tuberculosis, the causative agent of tuberculosis, is known to
secrete a number of highly immunogenic proteins that are thought to confer
pathogenicity, in part, by mediating binding to host tissues. Among these
secreted proteins are the trimeric antigen 85 (Ag85) complex and the related
MPT51 protein, also known as FbpC1. While the physiological function of Ag85, a
mycolyltransferase required for the biosynthesis of the cell wall component
alpha,alpha'-trehalose dimycolate (or cord factor), has been identified
recently, the function of the closely related MPT51 (approximately 40% identity
with the Ag85 components) remains to be established. The crystal structure of
M.tuberculosis MPT51, determined to 1.7 A resolution, shows that MPT51, like the
Ag85 components Ag85B and Ag85C2, folds as an alpha/beta hydrolase, but it does
not contain any of the catalytic elements required for mycolyltransferase
activity. Moreover, the absence of a recognizable alpha,alpha'-trehalose
monomycolate-binding site and the failure to detect an active site suggest that
the function of MPT51 is of a non-enzymatic nature and that MPT51 may in fact
represent a new family of non-catalytic alpha/beta hydrolases. Previous
experimental evidence and the structural similarity to some integrins and
carbohydrate-binding proteins led to the hypothesis that MPT51 might have a role
in host tissue attachment, whereby ligands may include the serum protein
fibronectin and small sugars.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Stereo views of the tertiary structure of MPT51,
the structural superimposition with Ag85C2 and of the "active
site". (a) Secondary structure is color-coded: green, b-sheet;
cyan, a-helix; dark blue, 3[10] helix. The residues
corresponding to the catalytic triad in the Ag85 subunits are
shown as rods (yellow, carbon; blue, nitrogen; red, oxygen). (b)
Illustration of structural differences between MPT51 and Ag85C2.
Ribbon in light and dark blue corresponds to the active and
inhibitor-bound forms of Ag85C2. The b7-a9 loop and helix a9 of
MPT51 is shown in red, the fibronectin-binding loop in green.
(c) Electron density (s[A]-weighted 2F[o] -F[c] map, 30-1.7
Å, after automatic backbone tracing in ARP/wARP, contour
level 1.2s) of the active site of MPT51 with the catalytic triad
of Ag85C2 superimposed (rods in light blue). The final refined
model of MPT51 is shown with rods color-coded as in (a). The
Figure was prepared using RIBBONS.[53.]
|
 |
Figure 3.
Figure 3. (a) Stereo view of cavities in Ag85C2 (gray)
versus MPT51 (cyan) superimposed with the ribbon diagram of
MPT51. The trehalose molecule of the structure of Ag85B[20.] is
shown as a guide for the eye. (b) Stereo view of the
superimposition of the structures of the effector domain of E.
coli TreR[37.] (blue) and of the S. typhimurium
glucose/galactose receptor[38.] (green) with MPT51 (gray). The
trehalose-6-phosphate ligand of TreR (red rods) and the
trehalose molecule (yellow) of the Ag85B structure are shown.
(c) and (d) Surface diagrams of (c) MPT51 and (d) Ag85B colored
according to sequence conservation (red=identity). The surface
area corresponding to the fibronectin-binding loop is marked in
green. The Figure was prepared using (a) SURFNET, [28.] (a) and
(b) RIBBONS [53.] and (c) GRASP. [54.]
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2004,
335,
519-530)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Henderson,
S.Nair,
J.Pallas,
and
M.A.Williams
(2011).
Fibronectin: a multidomain host adhesin targeted by bacterial fibronectin-binding proteins.
|
| |
FEMS Microbiol Rev,
35,
147-200.
|
 |
|
|
|
|
 |
G.Singh,
G.Singh,
D.Jadeja,
and
J.Kaur
(2010).
Lipid hydrolizing enzymes in virulence: Mycobacterium tuberculosis as a model system.
|
| |
Crit Rev Microbiol,
36,
259-269.
|
 |
|
|
|
|
 |
J.M.Achkar,
E.Jenny-Avital,
X.Yu,
S.Burger,
E.Leibert,
P.W.Bilder,
S.C.Almo,
A.Casadevall,
and
S.Laal
(2010).
Antibodies against immunodominant antigens of Mycobacterium tuberculosis in subjects with suspected tuberculosis in the United States compared by HIV status.
|
| |
Clin Vaccine Immunol,
17,
384-392.
|
 |
|
|
|
|
 |
K.R.Steingart,
N.Dendukuri,
M.Henry,
I.Schiller,
P.Nahid,
P.C.Hopewell,
A.Ramsay,
M.Pai,
and
S.Laal
(2009).
Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis.
|
| |
Clin Vaccine Immunol,
16,
260-276.
|
 |
|
|
|
|
 |
C.Melo Cardoso Almeida,
A.C.Vasconcelos,
A.Kipnis,
A.L.Andrade,
and
A.P.Junqueira-Kipnis
(2008).
Humoral immune responses of tuberculosis patients in Brazil indicate recognition of Mycobacterium tuberculosis MPT-51 and GlcB.
|
| |
Clin Vaccine Immunol,
15,
579-581.
|
 |
|
|
|
|
 |
T.Aoshi,
T.Nagata,
M.Suzuki,
M.Uchijima,
D.Hashimoto,
A.Rafiei,
T.Suda,
K.Chida,
and
Y.Koide
(2008).
Identification of an HLA-A*0201-restricted T-cell epitope on the MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis, by MPT51 overlapping peptide screening.
|
| |
Infect Immun,
76,
1565-1571.
|
 |
|
|
|
|
 |
B.Al-Sayyed,
S.Piperdi,
X.Yuan,
A.Li,
G.S.Besra,
W.R.Jacobs,
A.Casadevall,
and
A.Glatman-Freedman
(2007).
Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51.
|
| |
Tuberculosis (Edinb),
87,
489-497.
|
 |
|
|
|
|
 |
K.Takayama,
C.Wang,
and
G.S.Besra
(2005).
Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis.
|
| |
Clin Microbiol Rev,
18,
81.
|
 |
|
|
|
|
 |
L.Nguyen,
S.Chinnapapagari,
and
C.J.Thompson
(2005).
FbpA-Dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of Mycobacterium smegmatis.
|
| |
J Bacteriol,
187,
6603-6611.
|
 |
|
|
|
|
 |
A.Stark,
A.Shkumatov,
and
R.B.Russell
(2004).
Finding functional sites in structural genomics proteins.
|
| |
Structure,
12,
1405-1412.
|
 |
|
|
|
|
 |
I.Janda,
Y.Devedjiev,
D.Cooper,
M.Chruszcz,
U.Derewenda,
A.Gabrys,
W.Minor,
A.Joachimiak,
and
Z.S.Derewenda
(2004).
Harvesting the high-hanging fruit: the structure of the YdeN gene product from Bacillus subtilis at 1.8 angstroms resolution.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
1101-1107.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Canaan,
D.Maurin,
H.Chahinian,
B.Pouilly,
C.Durousseau,
F.Frassinetti,
L.Scappuccini-Calvo,
C.Cambillau,
and
Y.Bourne
(2004).
Expression and characterization of the protein Rv1399c from Mycobacterium tuberculosis. A novel carboxyl esterase structurally related to the HSL family.
|
| |
Eur J Biochem,
271,
3953-3961.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |